Literature DB >> 26720027

Acute Flaccid Myelitis of Unknown Etiology in California, 2012-2015.

Keith Van Haren1, Patrick Ayscue2, Emmanuelle Waubant3, Anna Clayton4, Heather Sheriff4, Shigeo Yagi4, Rose Glenn-Finer4, Tasha Padilla4, Jonathan B Strober3, Grace Aldrovandi5, Debra A Wadford4, Charles Y Chiu6, Dongxiang Xia4, Kathleen Harriman4, James P Watt4, Carol A Glaser7.   

Abstract

IMPORTANCE: There has been limited surveillance for acute flaccid paralysis in North America since the regional eradication of poliovirus. In 2012, the California Department of Public Health received several reports of acute flaccid paralysis cases of unknown etiology.
OBJECTIVE: To quantify disease incidence and identify potential etiologies of acute flaccid paralysis cases with evidence of spinal motor neuron injury. DESIGN, SETTING, AND PARTICIPANTS: Case series of acute flaccid paralysis in patients with radiological or neurophysiological findings suggestive of spinal motor neuron involvement reported to the California Department of Public Health with symptom onset between June 2012 and July 2015. Patients meeting diagnostic criteria for other acute flaccid paralysis etiologies were excluded. Cerebrospinal fluid, serum samples, nasopharyngeal swab specimens, and stool specimens were submitted to the state laboratory for infectious agent testing. MAIN OUTCOMES AND MEASURES: Case incidence and infectious agent association.
RESULTS: Fifty-nine cases were identified. Median age was 9 years (interquartile range [IQR], 4-14 years; 50 of the cases were younger than 21 years). Symptoms that preceded or were concurrent included respiratory or gastrointestinal illness (n = 54), fever (n = 47), and limb myalgia (n = 41). Fifty-six patients had T2 hyperintensity of spinal gray matter on magnetic resonance imaging and 43 patients had cerebrospinal fluid pleocytosis. During the course of the initial hospitalization, 42 patients received intravenous steroids; 43, intravenous immunoglobulin; and 13, plasma exchange; or a combination of these treatments. Among 45 patients with follow-up data, 38 had persistent weakness at a median follow-up of 9 months (IQR, 3-12 months). Two patients, both immunocompromised adults, died within 60 days of symptom onset. Enteroviruses were the most frequently detected pathogen in either nasopharynx swab specimens, stool specimens, serum samples (15 of 45 patients tested). No pathogens were isolated from the cerebrospinal fluid. The incidence of reported cases was significantly higher during a national enterovirus D68 outbreak occurring from August 2014 through January 2015 (0.16 cases per 100,000 person-years) compared with other monitoring periods (0.028 cases per 100,000 person-years; P <.001). CONCLUSIONS AND RELEVANCE: In this series of patients identified in California from June 2012 through July 2015, clinical manifestations indicated a rare but distinct syndrome of acute flaccid paralysis with evidence of spinal motor neuron involvement. The etiology remains undetermined, most patients were children and young adults, and motor weakness was prolonged.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26720027     DOI: 10.1001/jama.2015.17275

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  38 in total

1.  Clinical Subpopulations in a Sample of North American Children Diagnosed With Acute Flaccid Myelitis, 2012-2016.

Authors:  Matthew J Elrick; Eliza Gordon-Lipkin; Thomas O Crawford; Keith Van Haren; Kevin Messacar; Nicole Thornton; Elizabeth Dee; Annie Voskertchian; Jessica R Nance; Laura S Muñoz; Mark P Gorman; Leslie A Benson; David L Thomas; Carlos A Pardo; Aaron M Milstone; Priya Duggal
Journal:  JAMA Pediatr       Date:  2019-02-01       Impact factor: 16.193

2.  Outcomes of Colorado children with acute flaccid myelitis at 1 year.

Authors:  Jan A Martin; Kevin Messacar; Michele L Yang; John A Maloney; Jennifer Lindwall; Terri Carry; Patricia Kenyon; Stefan H Sillau; Joyce Oleszek; Kenneth L Tyler; Samuel R Dominguez; Teri L Schreiner
Journal:  Neurology       Date:  2017-06-14       Impact factor: 9.910

Review 3.  Acute Flaccid Paralysis and Enteroviral Infections.

Authors:  Ari Bitnun; E Ann Yeh
Journal:  Curr Infect Dis Rep       Date:  2018-06-29       Impact factor: 3.725

Review 4.  Acute Flaccid Myelitis: Etiologic Challenges, Diagnostic and Management Considerations.

Authors:  Sarah E Hopkins
Journal:  Curr Treat Options Neurol       Date:  2017-11-28       Impact factor: 3.598

5.  Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies.

Authors:  Elia Sechi; Karl N Krecke; Sean J Pittock; Divyanshu Dubey; A Sebastian Lopez-Chiriboga; Amy Kunchok; Brian G Weinshenker; Nicholas L Zalewski; Eoin P Flanagan
Journal:  Mult Scler       Date:  2020-02-27       Impact factor: 6.312

Review 6.  Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality.

Authors:  Kevin Messacar; Edwin J Asturias; Alison M Hixon; Coretta Van Leer-Buter; Hubert G M Niesters; Kenneth L Tyler; Mark J Abzug; Samuel R Dominguez
Journal:  Lancet Infect Dis       Date:  2018-02-23       Impact factor: 25.071

Review 7.  Acute flaccid myelitis: A clinical review of US cases 2012-2015.

Authors:  Kevin Messacar; Teri L Schreiner; Keith Van Haren; Michele Yang; Carol A Glaser; Kenneth L Tyler; Samuel R Dominguez
Journal:  Ann Neurol       Date:  2016-08-04       Impact factor: 10.422

8.  Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68-Associated Paralytic Myelitis.

Authors:  Alison M Hixon; Penny Clarke; Kenneth L Tyler
Journal:  J Infect Dis       Date:  2017-12-05       Impact factor: 5.226

9.  Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis.

Authors:  Kevin Messacar; Stefan Sillau; Sarah E Hopkins; Catherine Otten; Molly Wilson-Murphy; Brian Wong; Jonathan D Santoro; Andrew Treister; Harlori K Bains; Alcy Torres; Luke Zabrocki; Julia R Glanternik; Amanda L Hurst; Jan A Martin; Teri Schreiner; Naila Makhani; Roberta L DeBiasi; Michael C Kruer; Adriana H Tremoulet; Keith Van Haren; Jay Desai; Leslie A Benson; Mark P Gorman; Mark J Abzug; Kenneth L Tyler; Samuel R Dominguez
Journal:  Neurology       Date:  2018-11-09       Impact factor: 9.910

Review 10.  Acute flaccid myelitis: cause, diagnosis, and management.

Authors:  Olwen C Murphy; Kevin Messacar; Leslie Benson; Riley Bove; Jessica L Carpenter; Thomas Crawford; Janet Dean; Roberta DeBiasi; Jay Desai; Matthew J Elrick; Raquel Farias-Moeller; Grace Y Gombolay; Benjamin Greenberg; Matthew Harmelink; Sue Hong; Sarah E Hopkins; Joyce Oleszek; Catherine Otten; Cristina L Sadowsky; Teri L Schreiner; Kiran T Thakur; Keith Van Haren; Carolina M Carballo; Pin Fee Chong; Amary Fall; Vykuntaraju K Gowda; Jelte Helfferich; Ryutaro Kira; Ming Lim; Eduardo L Lopez; Elizabeth M Wells; E Ann Yeh; Carlos A Pardo
Journal:  Lancet       Date:  2020-12-23       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.